NCT02004808Unknown不适用
Neutrophil Extracellular Traps and Sickle Cell Disease
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 15
- 主要终点
- measurements of neutrophil function
研究概览
简要总结
NETs formation in vaso-occlusive events in sickle cell disease and the role of hydroxyurea treatment.The study hypothesis is that NETs formation by neutrophils has a role in the induction of vaso occlusive disease in blood vessels. It is possible that high leukocyte count in children with sickle cell anemia is a bad prognostic sign due to NETs formation supporting occlusion of peripheral and central blood vessels.Hydroxyurea treatment might prevent vaso occlusive syndrome not only by increasing HbF but also by decreasing neutrophil count and inhibiting NETs formation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Month 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •children who suffer from sickle cell disease and/or children with sickle cell disease treated with hydroxyurea
排除标准
- 未提供
结局指标
主要结局
measurements of neutrophil function
时间窗: at first admition (day 1)
次要结局
- measurements of neutrophil function(at sickle cell crisis while hospitalized)
研究者
相似试验
已完成
不适用
Inflammatory Response to Hydroxyurea Therapy in Sickle Cell DiseaseSickle Cell DiseaseNCT00784082Assistance Publique - Hôpitaux de Paris62
招募中
不适用
Neutrophil Extracellular Traps in Different Forms of Systemic SclerosisOther Connective Tissue DiseaseANCA Associated VasculitisSystemic Lupus ErythematosusSystemic SclerosisDermatomyositisNCT06462768CHU de Reims260
已完成
1 期
Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaSickle Cell DiseaseChronic Kidney DiseasePulmonary HypertensionNCT00270478National Heart, Lung, and Blood Institute (NHLBI)7
已完成
2 期
Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)Anemia, Sickle CellHematologic DiseasesHemoglobinopathiesNCT00000602National Heart, Lung, and Blood Institute (NHLBI)
已完成
4 期
Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)Renal Function DisorderSickle Cell DiseaseNCT02522104Theravia40
